A citation-based method for searching scientific literature

Thomas Delerue, Déborah Tribouillard-Tanvier, Marlène Daloyau, Farnoosh Khosrobakhsh, Laurent Jean Emorine, Gaëlle Friocourt, Pascale Belenguer, Marc Blondel, Laetitia Arnauné-Pelloquin. Dis Model Mech 2019
Times Cited: 8







List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies.
Jean-Paul Lasserre, Alain Dautant, Raeka S Aiyar, Roza Kucharczyk, Annie Glatigny, Déborah Tribouillard-Tanvier, Joanna Rytka, Marc Blondel, Natalia Skoczen, Pascal Reynier,[...]. Dis Model Mech 2015
74
50

A yeast-based assay identifies drugs active against human mitochondrial disorders.
Elodie Couplan, Raeka S Aiyar, Roza Kucharczyk, Anna Kabala, Nahia Ezkurdia, Julien Gagneur, Robert P St Onge, Bénédicte Salin, Flavie Soubigou, Marie Le Cann,[...]. Proc Natl Acad Sci U S A 2011
59
37

In vivo analysis of mtDNA replication defects in yeast.
Enrico Baruffini, Iliana Ferrero, Françoise Foury. Methods 2010
43
37

Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations.
Serena J Aleo, Valentina Del Dotto, Mario Fogazza, Alessandra Maresca, Tiziana Lodi, Paola Goffrini, Anna Ghelli, Michela Rugolo, Valerio Carelli, Enrico Baruffini,[...]. Hum Mol Genet 2021
7
42

Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.
Patrick Yu-Wai-Man, Philip G Griffiths, Patrick F Chinnery. Prog Retin Eye Res 2011
348
25

Influence of Opa1 Mutation on Survival and Function of Retinal Ganglion Cells.
Irene González-Menéndez, Katja Reinhard, Jorge Tolivia, Bernd Wissinger, Thomas A Münch. Invest Ophthalmol Vis Sci 2015
13
25


Mitochondrial protein sorting as a therapeutic target for ATP synthase disorders.
Raeka S Aiyar, Maria Bohnert, Stéphane Duvezin-Caubet, Cécile Voisset, Julien Gagneur, Emilie S Fritsch, Elodie Couplan, Karina von der Malsburg, Charlotta Funaya, Flavie Soubigou,[...]. Nat Commun 2014
18
25

Multi-system neurological disease is common in patients with OPA1 mutations.
P Yu-Wai-Man, P G Griffiths, G S Gorman, C M Lourenco, A F Wright, M Auer-Grumbach, A Toscano, O Musumeci, M L Valentino, L Caporali,[...]. Brain 2010
268
25

Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.
C Delettre, G Lenaers, J M Griffoin, N Gigarel, C Lorenzo, P Belenguer, L Pelloquin, J Grosgeorge, C Turc-Carel, E Perret,[...]. Nat Genet 2000
25

Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy.
Cecilia Nolli, Paola Goffrini, Mirca Lazzaretti, Claudia Zanna, Rita Vitale, Tiziana Lodi, Enrico Baruffini. Mitochondrion 2015
14
25

Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severity.
Juan Manuel Chao de la Barca, Mario Fogazza, Michela Rugolo, Stéphanie Chupin, Valentina Del Dotto, Anna Maria Ghelli, Valerio Carelli, Gilles Simard, Vincent Procaccio, Dominique Bonneau,[...]. Hum Mol Genet 2020
9
25

Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1.
Shelly Meeusen, Rachel DeVay, Jennifer Block, Ann Cassidy-Stone, Sarah Wayson, J Michael McCaffery, Jodi Nunnari. Cell 2006
316
25

Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin.
Tadato Ban, Takaya Ishihara, Hiroto Kohno, Shotaro Saita, Ayaka Ichimura, Katsumi Maenaka, Toshihiko Oka, Katsuyoshi Mihara, Naotada Ishihara. Nat Cell Biol 2017
152
25

Defective mitochondrial fusion, altered respiratory function, and distorted cristae structure in skin fibroblasts with heterozygous OPA1 mutations.
Virginie Agier, Patricia Oliviero, Jeanne Lainé, Caroline L'Hermitte-Stead, Samantha Girard, Sandrine Fillaut, Claude Jardel, Frédéric Bouillaud, Anne Laure Bulteau, Anne Lombès. Biochim Biophys Acta 2012
40
25

OPA1: How much do we know to approach therapy?
Valentina Del Dotto, Mario Fogazza, Guy Lenaers, Michela Rugolo, Valerio Carelli, Claudia Zanna. Pharmacol Res 2018
19
25

Eight human OPA1 isoforms, long and short: What are they for?
Valentina Del Dotto, Mario Fogazza, Valerio Carelli, Michela Rugolo, Claudia Zanna. Biochim Biophys Acta Bioenerg 2018
64
25


OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation.
Tadato Ban, Jürgen A W Heymann, Zhiyin Song, Jenny E Hinshaw, David C Chan. Hum Mol Genet 2010
144
25

Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy.
Mariame Selma Kane, Jennifer Alban, Valérie Desquiret-Dumas, Naïg Gueguen, Layal Ishak, Marc Ferre, Patrizia Amati-Bonneau, Vincent Procaccio, Dominique Bonneau, Guy Lenaers,[...]. J Cell Mol Med 2017
24
25

The dynamin-related GTPase, Mgm1p, is an intermembrane space protein required for maintenance of fusion competent mitochondria.
E D Wong, J A Wagner, S W Gorsich, J M McCaffery, J M Shaw, J Nunnari. J Cell Biol 2000
249
25

Structure and assembly of the mitochondrial membrane remodelling GTPase Mgm1.
Katja Faelber, Lea Dietrich, Jeffrey K Noel, Florian Wollweber, Anna-Katharina Pfitzner, Alexander Mühleip, Ricardo Sánchez, Misha Kudryashev, Nicolas Chiaruttini, Hauke Lilie,[...]. Nature 2019
42
25

A novel role of Mgm1p, a dynamin-related GTPase, in ATP synthase assembly and cristae formation/maintenance.
Boominathan Amutha, Donna M Gordon, Yajuan Gu, Debkumar Pain. Biochem J 2004
60
25

Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency.
Sara Cogliati, Christian Frezza, Maria Eugenia Soriano, Tatiana Varanita, Ruben Quintana-Cabrera, Mauro Corrado, Sara Cipolat, Veronica Costa, Alberto Casarin, Ligia C Gomes,[...]. Cell 2013
629
25

Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy.
C Verny, D Loiseau, C Scherer, P Lejeune, A Chevrollier, N Gueguen, V Guillet, F Dubas, P Reynier, P Amati-Bonneau,[...]. Neurology 2008
41
25

Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models.
Valentina Del Dotto, Mario Fogazza, Francesco Musiani, Alessandra Maresca, Serena J Aleo, Leonardo Caporali, Chiara La Morgia, Cecilia Nolli, Tiziana Lodi, Paola Goffrini,[...]. Biochim Biophys Acta Mol Basis Dis 2018
23
25


Nonsyndromic Parkinson disease in a family with autosomal dominant optic atrophy due to OPA1 mutations.
David S Lynch, Samantha H Y Loh, Jasmine Harley, Alastair J Noyce, L Miguel Martins, Nicholas W Wood, Henry Houlden, Helene Plun-Favreau. Neurol Genet 2017
15
25

OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28.
C Alexander, M Votruba, U E Pesch, D L Thiselton, S Mayer, A Moore, M Rodriguez, U Kellner, B Leo-Kottler, G Auburger,[...]. Nat Genet 2000
927
25

OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Emmanuelle Sarzi, Marie Seveno, Camille Piro-Mégy, Lucie Elzière, Mélanie Quilès, Marie Péquignot, Agnès Müller, Christian P Hamel, Guy Lenaers, Cécile Delettre. Sci Rep 2018
24
25

The intramitochondrial dynamin-related GTPase, Mgm1p, is a component of a protein complex that mediates mitochondrial fusion.
Edith D Wong, Jennifer A Wagner, Sidney V Scott, Voytek Okreglak, Timothy J Holewinske, Ann Cassidy-Stone, Jodi Nunnari. J Cell Biol 2003
187
25

Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency.
Aida Rodríguez-Nuevo, Angels Díaz-Ramos, Eduard Noguera, Francisco Díaz-Sáez, Xavier Duran, Juan Pablo Muñoz, Montserrat Romero, Natàlia Plana, David Sebastián, Caterina Tezze,[...]. EMBO J 2018
76
25

Syndromic parkinsonism and dementia associated with OPA1 missense mutations.
Valerio Carelli, Olimpia Musumeci, Leonardo Caporali, Claudia Zanna, Chiara La Morgia, Valentina Del Dotto, Anna Maria Porcelli, Michela Rugolo, Maria Lucia Valentino, Luisa Iommarini,[...]. Ann Neurol 2015
100
25

OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution.
Ghizlane Elachouri, Sara Vidoni, Claudia Zanna, Alexandre Pattyn, Hassan Boukhaddaoui, Karen Gaget, Patrick Yu-Wai-Man, Giuseppe Gasparre, Emmanuelle Sarzi, Cécile Delettre,[...]. Genome Res 2011
148
25

OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.
Christian Frezza, Sara Cipolat, Olga Martins de Brito, Massimo Micaroni, Galina V Beznoussenko, Tomasz Rudka, Davide Bartoli, Roman S Polishuck, Nika N Danial, Bart De Strooper,[...]. Cell 2006
25

OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.
Claudia Zanna, Anna Ghelli, Anna Maria Porcelli, Mariusz Karbowski, Richard J Youle, Simone Schimpf, Bernd Wissinger, Marcello Pinti, Andrea Cossarizza, Sara Vidoni,[...]. Brain 2008
234
25

OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.
Patrizia Amati-Bonneau, Maria Lucia Valentino, Pascal Reynier, Maria Esther Gallardo, Belén Bornstein, Anne Boissière, Yolanda Campos, Henry Rivera, Jesús González de la Aleja, Rosanna Carroccia,[...]. Brain 2008
348
25

Mgm1p, a dynamin-related GTPase, is essential for fusion of the mitochondrial outer membrane.
Hiromi Sesaki, Sheryl M Southard, Michael P Yaffe, Robert E Jensen. Mol Biol Cell 2003
195
25

Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.
Gavin Hudson, Patrizia Amati-Bonneau, Emma L Blakely, Joanna D Stewart, Langping He, Andrew M Schaefer, Philip G Griffiths, Kati Ahlqvist, Anu Suomalainen, Pascal Reynier,[...]. Brain 2008
281
25

Identification of a fission yeast dynamin-related protein involved in mitochondrial DNA maintenance.
L Pelloquin, P Belenguer, Y Menon, B Ducommun. Biochem Biophys Res Commun 1998
61
25

OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L.
Zhiyin Song, Hsiuchen Chen, Maja Fiket, Christiane Alexander, David C Chan. J Cell Biol 2007
513
25

Cryo-EM structures of S-OPA1 reveal its interactions with membrane and changes upon nucleotide binding.
Danyang Zhang, Yan Zhang, Jun Ma, Chunmei Zhu, Tongxin Niu, Wenbo Chen, Xiaoyun Pang, Yujia Zhai, Fei Sun. Elife 2020
12
25

OPA1 Isoforms in the Hierarchical Organization of Mitochondrial Functions.
Valentina Del Dotto, Prashant Mishra, Sara Vidoni, Mario Fogazza, Alessandra Maresca, Leonardo Caporali, J Michael McCaffery, Martina Cappelletti, Enrico Baruffini, Guy Lenaers,[...]. Cell Rep 2017
89
25

OPA1-associated disorders: phenotypes and pathophysiology.
Patrizia Amati-Bonneau, Dan Milea, Dominique Bonneau, Arnaud Chevrollier, Marc Ferré, Virginie Guillet, Naïg Gueguen, Dominique Loiseau, Marie-Anne Pou de Crescenzo, Christophe Verny,[...]. Int J Biochem Cell Biol 2009
98
25

OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.
Patrizia Amati-Bonneau, Agnès Guichet, Aurélien Olichon, Arnaud Chevrollier, Frédérique Viala, Stéphanie Miot, Carmen Ayuso, Sylvie Odent, Catherine Arrouet, Christophe Verny,[...]. Ann Neurol 2005
110
25

Two forms of Opa1 cooperate to complete fusion of the mitochondrial inner-membrane.
Yifan Ge, Xiaojun Shi, Sivakumar Boopathy, Julie McDonald, Adam W Smith, Luke H Chao. Elife 2020
31
25

Strategies for fighting mitochondrial diseases.
C Viscomi, M Zeviani. J Intern Med 2020
19
25





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.